Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Arthritis and Rheumatism|October 31, 2009
Classification, presentation, and initial treatment of Wegener's granulomatosis in childhoodDavid A Cabral, América G Uribe, Susanne Benseler, et al.
The Journal of Rheumatology|February 17, 2012
Assessing the performance of the Birmingham Vasculitis Activity Score at diagnosis for children with antineutrophil cytoplasmic antibody-associated vasculitis in A Registry for Childhood Vasculitis (ARChiVe)Kimberly Morishita, Suzanne C Li, Eyal Muscal, et al.
The Journal of Rheumatology|May 17, 2012
Increased sensitivity of the European medicines agency algorithm for classification of childhood granulomatosis with polyangiitisAmérica G Uribe, Adam M Huber, Susan Kim, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 3, 2024
Evaluating Renal Disease in Pediatric-Onset Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Disease Course, Outcomes, and Predictors of OutcomeKirandeep K Toor, Audrea Chen, David A Cabral, et al.
Arthritis Care & Research|March 2, 2022
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and ImagingKaren B Onel, Daniel B Horton, Daniel J Lovell, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 2, 2022
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic ArthritisKaren B Onel, Daniel B Horton, Daniel J Lovell, et al.
Arthritis Care & Research|October 22, 2014
Novel method to collect medication adverse events in juvenile arthritis: results from the childhood arthritis and rheumatology research alliance enhanced drug safety surveillance projectSarah Ringold, Audrey Hendrickson, Leslie Abramson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 2, 2022
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and ImagingKaren B Onel, Daniel B Horton, Daniel J Lovell, et al.
Arthritis Care & Research|March 2, 2022
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic ArthritisKaren B Onel, Daniel B Horton, Daniel J Lovell, et al.
The Journal of Rheumatology|August 4, 2012
Do adult disease severity subclassifications predict use of cyclophosphamide in children with ANCA-associated vasculitis? An analysis of ARChiVe study treatment decisionsKimberly Morishita, Jaime Guzman, Peter Chira, et al.
Pageof 5